Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Wei

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Trials|November 29, 2023
Supporting physical activity for mobility in older adults with mobility limitations (SuPA Mobility): study protocol for a randomized controlled trialJordyn Rice, Linda C Li, Jennifer C Davis, et al.
CJC Pediatric and Congenital Heart Disease|November 16, 2023
Medical Management of Infants With Supraventricular Tachycardia: Results From a Registry and Review of the LiteratureNathan Wei, Avani Lamba, Sonia Franciosi, et al.
The Journal of Rheumatology|December 25, 2009
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 StudyPhilip J Mease, Nathan Wei, Edward J Fudman, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Trials|November 29, 2023
Supporting physical activity for mobility in older adults with mobility limitations (SuPA Mobility): study protocol for a randomized controlled trialJordyn Rice, Linda C Li, Jennifer C Davis, et al.
CJC Pediatric and Congenital Heart Disease|November 16, 2023
Medical Management of Infants With Supraventricular Tachycardia: Results From a Registry and Review of the LiteratureNathan Wei, Avani Lamba, Sonia Franciosi, et al.
The Journal of Rheumatology|December 25, 2009
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 StudyPhilip J Mease, Nathan Wei, Edward J Fudman, et al.
Pageof 3